AIHC Capital Management Ltd — 13F Holdings & Portfolio
CIK 2103725 · latest 13F-HR filed 2026-05-08
AIHC Capital Management Ltd manages $119.7M in 13F-reported U.S. long-equity assets across 5 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are RVMD (67.37%), ORIC (26.04%), NBP (4.65%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 1 new position, exited 2, added to 3, and trimmed 1.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$119.7M
Long-equity book
5
Distinct positions
2026-03-31
Filed 2026-05-08
+1 / −2 / ↑3 / ↓1
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- REVOLUTION MEDICINES INC$8.9M +12.4%
- NOVABRIDGE BIOSCIENCES$3.9M +237.9%
- KORRO BIO INC$100.2K +41.3%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $80.6M | 67.37% | 828,974 | SH |
| 2 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $31.2M | 26.04% | 2,459,551 | SH |
| 3 | NOVABRIDGE BIOSCIENCES | NBP | 44975P103 | $5.6M | 4.65% | 2,262,933 | SH |
| 4 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $2.0M | 1.65% | 51,402 | SH |
| 5 | KORRO BIO INC | KRRO | 500946108 | $342.6K | 0.29% | 30,265 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | $119.7M | 5 | 0001172661-26-001629 |
| 2025-12-31 | 2026-02-05 | $106.7M | 6 | 0001172661-26-000478 |